Related references
Note: Only part of the references are listed.Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment
Manabu Kato et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial
Yiming Mu et al.
JOURNAL OF DIABETES (2018)
Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy
Zohaib Iqbal et al.
CLINICAL THERAPEUTICS (2018)
The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions
Jinjun Chen et al.
CELL REPORTS (2018)
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
Rodica Pop-Busui et al.
DIABETES CARE (2017)
The noradrenergic locus coeruleus as a chronic pain generator
Bradley K. Taylor et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Glycemic and serum lipid control in patients with painful diabetic peripheral neuropathy treated with pregabalin
Bruce Parsons et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
UK government to reclassify pregabalin and gabapentin after rise in deaths
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2017)
UK government to reclassify pregabalin and gabapentin after rise in deaths
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2017)
A systematic review of treatment of Painful Diabetic Neuropathy by Pain Phenotype versus treatment Based on Medical comorbidities
Luiz Clemente Rolim et al.
FRONTIERS IN NEUROLOGY (2017)
Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
Michael Serpell et al.
JOURNAL OF PAIN RESEARCH (2017)
Neuropathic Pain and Sleep: A Review
Luigi Ferini-Strambi
PAIN AND THERAPY (2017)
Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers
Yvonne D'Arcy et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
The Modulation of Pain by Circadian and Sleep-Dependent Processes: A Review of the Experimental Evidence
Megan Hastings Hagenauer et al.
WOMEN IN MATHEMATICAL BIOLOGY (2017)
Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions
Setsuro Ogawa et al.
CLINICAL DRUG INVESTIGATION (2016)
Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions A Double-Blind Crossover Study
Philip Raskin et al.
CLINICAL JOURNAL OF PAIN (2016)
The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy
Bruce Parsons et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Comparison of oral absorption models for pregabalin: usefulness of transit compartment model
Taegon Hong et al.
Drug Design Development and Therapy (2016)
Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking
Cynthia Huffman et al.
CLINICAL JOURNAL OF PAIN (2015)
Corneal Confocal Microscopy Predicts 4-Year Incident Peripheral Neuropathy in Type 1 Diabetes
Nicola Pritchard et al.
DIABETES CARE (2015)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015 —EXECUTIVE SUMMARY
Yehuda Handelsman et al.
Endocrine Practice (2015)
Biological and Pharmacological Aspects of the NK1-Receptor
Susana Garcia-Recio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta-analysis
S-S. Zhang et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2015)
Corneal Confocal Microscopy Shows an Improvement in Small-Fiber Neuropathy in Subjects With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection
Shazli Azmi et al.
DIABETES CARE (2015)
A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
Rainer Freynhagen et al.
PAIN PRACTICE (2015)
Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder
James E. Frampton
CNS DRUGS (2014)
Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?
Fabrizio Schifano
CNS DRUGS (2014)
Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Vivek Verma et al.
CURRENT NEUROPHARMACOLOGY (2014)
Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled, Adaptive Proof-of-Concept Phase 2 Study
Aaron Vinik et al.
DIABETES CARE (2014)
Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study
Didier Bouhassira et al.
PAIN (2014)
Phantom Limb Pain: A Systematic Neuroanatomical-Based Review of Pharmacologic Treatment
Zachary McCormick et al.
PAIN MEDICINE (2014)
Prediction of Pregabalin-Mediated Pain Response by Severity of Sleep Disturbance in Patients with Painful Diabetic Neuropathy and Post-Herpetic Neuralgia
Aaron Vinik et al.
PAIN MEDICINE (2014)
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain
Cory Toth
THERAPEUTIC ADVANCES IN DRUG SAFETY (2014)
Pre- and postsynaptic inhibitory control in the spinal cord dorsal horn
Rita Bardoni et al.
NEURONS, CIRCUITRY, AND PLASTICITY IN THE SPINAL CORD AND BRAINSTEM (2013)
Chronobiological Characteristics of Neuropathic Pain Clinical Predictors of Diurnal Pain Rhythmicity
Ian Gilron et al.
CLINICAL JOURNAL OF PAIN (2013)
α2δ-1 Gene Deletion Affects Somatosensory Neuron Function and Delays Mechanical Hypersensitivity in Response to Peripheral Nerve Damage
Ryan Patel et al.
JOURNAL OF NEUROSCIENCE (2013)
A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury
Diana D. Cardenas et al.
NEUROLOGY (2013)
Duloxetine and pregabalin: High-dose monotherapy or their combination? The COMBO-DN study'' - a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain
Solomon Tesfaye et al.
PAIN (2013)
Activation of NK1 receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain
Y. Muto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain
Julia Boyle et al.
DIABETES CARE (2012)
FAST SYNAPTIC INHIBITION IN SPINAL SENSORY PROCESSING AND PAIN CONTROL
Hanns Ulrich Zeilhofer et al.
PHYSIOLOGICAL REVIEWS (2012)
An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings
Marina de Salas-Cansado et al.
PRIMARY CARE DIABETES (2012)
Pregabalin for Peripheral Neuropathic Pain: A Multicenter, Enriched Enrollment Randomized Withdrawal Placebo-controlled Trial
Ian Gilron et al.
CLINICAL JOURNAL OF PAIN (2011)
Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China
Yuzhou Guan et al.
CLINICAL THERAPEUTICS (2011)
Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial
J. Satoh et al.
DIABETIC MEDICINE (2011)
The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials
Gaetano Zaccara et al.
EPILEPSIA (2011)
Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits
Zheng Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Evidence-based guideline: Treatment of painful diabetic neuropathy
V. Bril et al.
NEUROLOGY (2011)
Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial
Jo Satoh et al.
JOURNAL OF DIABETES INVESTIGATION (2011)
Familial pain syndromes from mutations of the Na(v)1.7 sodium channel
Tanya Z. Fischer et al.
YEAR IN NEUROLOGY 2 (2010)
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies
David Semel et al.
BMC FAMILY PRACTICE (2010)
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Howard N. Bockbrader et al.
CLINICAL PHARMACOKINETICS (2010)
Efficacy and Tolerability of Pregabalin Using a Flexible, Optimized Dose Schedule in Korean Patients With Peripheral Neuropathic Pain: A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Dong Eon Moon et al.
CLINICAL THERAPEUTICS (2010)
The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials
Thomas Roth et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
N. Attal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers
Howard N. Bockbrader et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study
Christian Lampl et al.
JOURNAL OF NEUROLOGY (2010)
A Randomized, Controlled Trial of Oxycodone Versus Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With Pregabalin
Che S. Zin et al.
JOURNAL OF PAIN (2010)
Effects of Early Mobilization on Unhealed Dysvascular Transtibial Amputation Stumps: A Clinical Trial
Ernest R. VanRoss et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2009)
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
Sibilia Quilici et al.
BMC NEUROLOGY (2009)
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy
Ralf Baron et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics
K. Van Acker et al.
DIABETES & METABOLISM (2009)
Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial
D. Bansal et al.
DIABETIC MEDICINE (2009)
The Increased Trafficking of the Calcium Channel Subunit α2δ-1 to Presynaptic Terminals in Neuropathic Pain Is Inhibited by the α2δ Ligand Pregabalin
Claudia S. Bauer et al.
JOURNAL OF NEUROSCIENCE (2009)
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
Ian Gilron et al.
LANCET (2009)
NORADRENERGIC NEURONS IN THE LOCUS COERULEUS CONTRIBUTE TO NEUROPATHIC PAIN
J. J. Brightwell et al.
NEUROSCIENCE (2009)
Gabapentin Acts within the Locus Coeruleus to Alleviate Neuropathic Pain
Ken-ichiro Hayashida et al.
ANESTHESIOLOGY (2008)
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
Joseph C. Arezzo et al.
BMC NEUROLOGY (2008)
Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy - Findings from seven randomized, controlled trials across a range of doses
Roy Freeman et al.
DIABETES CARE (2008)
Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study
Ralf Baron et al.
EUROPEAN JOURNAL OF PAIN (2008)
Pregabalin for relief of neuropathic pain associated with diabetic neuropathy:: A randomized, double-blind study
Thomas Toelle et al.
EUROPEAN JOURNAL OF PAIN (2008)
Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia
M. J. Rodriguez et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders
Daniel M. Tassone et al.
CLINICAL THERAPEUTICS (2007)
Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin
Mark J. Field et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective
Jean-Eric Tarride et al.
CLINICAL THERAPEUTICS (2006)
Sleep impairment in patients with painful diabetic peripheral neuropathy
Diane C. Zelman et al.
CLINICAL JOURNAL OF PAIN (2006)
Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons
Kristina D. Micheva et al.
MOLECULAR PHARMACOLOGY (2006)
Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease
C Richardson et al.
CLINICAL JOURNAL OF PAIN (2006)
Algorithm for neuropathic pain treatment: An evidence based proposal
NB Finnerup et al.
PAIN (2005)
Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
R Freynhagen et al.
PAIN (2005)
Diabetic neuropathies - A statement by the American Diabetes Association
AJM Boulton et al.
DIABETES CARE (2005)
Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
RW Richter et al.
JOURNAL OF PAIN (2005)
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial
J Rosenstock et al.
PAIN (2004)
Pregabalin relieves symptoms of painful diabetic neuropathy - A randomized controlled trial
H Lesser et al.
NEUROLOGY (2004)
Pregabalin pharmacology and its relevance to clinical practice
E Ben-Menachem
EPILEPSIA (2004)
Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain
JAM Coull et al.
NATURE (2003)
The health care costs of diabetic peripheral neuropathy in the US
A Gordois et al.
DIABETES CARE (2003)
Pharmacokinetics of pregabalin in subjects with various degrees of renal function
EJ Randinitis et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample
LA McWilliams et al.
PAIN (2003)
Phantom pain and health-related quality of life in lower limb amputees
CP van der Schans et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Patient information on phantom limb pain: a focus group study of patient experiences, perceptions and opinions
CM Mortimer et al.
HEALTH EDUCATION RESEARCH (2002)
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
K Fink et al.
NEUROPHARMACOLOGY (2002)
Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life
BS Galer et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2000)
Share Paper
